China Export Growth Surges in April as Global Buyers Rush to Secure Supplies 
Aker BP Q1 Profit Jumps on Higher Oil Prices and Asset Reversal 
BMW Keeps 2026 Outlook Despite 25% Profit Drop Amid Tariff Pressure 
CoreWeave Q1 2026 Revenue Surges as AI Infrastructure Demand Grows 
Hua Hong Semiconductor Stock Surges to Multi-Year High Amid AI Boom 
Dollar Slips as Strong U.S. Jobs Data Reduces Fed Rate Cut Expectations 
Broadcom Eyes $35 Billion AI Chip Financing Deal With Apollo and Blackstone 
Iran-U.S. Peace Deal Near as Oil Prices Fall and Nuclear Disputes Persist 
Wall Street Hits Record High as AI Chip Stocks and Strong U.S. Jobs Data Boost Markets 
Gold Prices Rise as Weaker Dollar and U.S.-Iran Peace Hopes Boost Demand 
China EV Truck Boom Accelerates as Iran War Drives Diesel Prices Higher 
Orsted Q1 EBITDA Beats Expectations Despite U.S. Impairments 
AWS Data Center Overheating Disrupts Cloud Services in Northern Virginia 
Lufthansa Q1 Loss Narrows as Strong Summer Travel Demand Boosts Outlook 
Japan Tech Stocks Surge as AI Optimism Lifts SoftBank, Chipmakers 
Nike Tariff Refund Lawsuit Sparks Consumer Backlash Over Price Increases 
China-Made Fireworks Power U.S. Independence Day Celebrations Amid Trade Truce 
Celltrion revealed on Thursday, Sept. 23, that it would be supplying its rapid COVID-19 test kit called DiaTrust to the US government. This happened after the nation’s Department of Defense awarded the contract to them.
The South Korean biopharma stated that starting October 1st, its American division, Celltrion USA, will begin delivering the DiaTrust rapid test kits to 25,000 locations. The sites include nursing homes, coronavirus testing centers, and military facilities.
According to The Korea Herald, based on the agreement signed by Celltrion and the US Defense Logistics Agency, the United States could purchase additional kits if necessary. For the initial supply, the amount of the contract is said to be $626.61 million or 738.2 billion in Korean won.
Details for the initial order, like how many would be delivered was not disclosed. However, the publication stated that Bloomberg mentioned that the deal was for a total of 19 million DiaTrust test kits. With its contract with the DOD, Celltrion became the US’ largest supplier of rapid COVID-19 test kits.
“The fact that we were awarded a procurement contract by the DLA after having passed its strict screen process is a recognition of Celltrion’s technology and supply capability,” Celltrion USA chief executive officer, Bonjoong Kim, said in a press release. “With the COVID-19 pandemic still not showing signs of waning, we plan to focus on executing this contract as diligently as possible and further solidify the external credibility of Celltrion’s diagnostic test kits portfolio.”
It was added that the DiaTrust kits that will be delivered through this deal are point-of-care tests (POCT). This means that the COVID-19 rapid test will only be used in the presence of medical professionals. Apparently, this is for safety and to ensure that the process is done properly for more accurate results.
As per Pulse News, DiaTrust was jointly developed by Celltrion and Humasis, a Korean R&D company. The test kit was authorized by the US Food and Drug Administration (FDA) for emergency use last April.
Finally, Celltrion’s DiaTrust rapid COVID-19 kit is an antigen test that is used in medical settings. It can reveal the results on the spot since it only takes as little as 15 minutes to complete.
